Reports for MYLAN PHARMACEUTICALS ULC
Company Name
MYLAN PHARMACEUTICALS ULC
Totals |
||
Shortage reports |
643 |
|
| Actual shortage: | 11 (2%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 85 (13%) | |
| Resolved: | 546 (85%) | |
Discontinuation Reports |
234 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 234 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
81 (9%) |
|
Overdue reports |
0 (0%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MYLAN-VERAPAMIL SR | 120MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-04-20 | 2021-05-27 | 137769 |
| MYLAN-VERAPAMIL SR | 240MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2023-03-27 | 2023-03-27 | 188108 |
| MYLAN-VERAPAMIL SR | 180MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2023-03-27 | 2024-02-22 | 188111 |
| MYLAN-VERAPAMIL SR | 120MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-08-01 | 2024-02-21 | 200642 |
| MYLAN-NIFEDIPINE EXTENDED RELEASE | 30MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-11-06 | 2023-11-14 | 209413 |
| MYLAN-GLICLAZIDE MR | 30MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2024-04-01 | 2024-04-16 | 224058 |
| MYLAN-NAPROXEN/ESOMEPRAZOLE MR | 20MG 500MG | TABLET (IMMEDIATE AND DELAYED-RELEASE) | Resolved | 2017-06-21 | 2019-05-23 | 13528 |
| MYLAN-NAPROXEN/ESOMEPRAZOLE MR | 20MG 375MG | TABLET (IMMEDIATE AND DELAYED-RELEASE) | Resolved | 2017-06-21 | 2018-02-03 | 13532 |
| MYLAN-NAPROXEN/ESOMEPRAZOLE MR | 20MG 500MG | TABLET (IMMEDIATE AND DELAYED-RELEASE) | Avoided shortage | 2019-06-04 | 2019-06-18 | 85554 |
| MYLAN-NAPROXEN/ESOMEPRAZOLE MR | 20MG 500MG | TABLET (IMMEDIATE AND DELAYED-RELEASE) | Resolved | 2019-06-25 | 2019-07-17 | 87460 |
| MYLAN-NAPROXEN/ESOMEPRAZOLE MR | 375MG 20MG | TABLET (IMMEDIATE AND DELAYED-RELEASE) | Resolved | 2020-07-02 | 2020-10-01 | 119316 |
| MYLAN-NAPROXEN/ESOMEPRAZOLE MR | 500MG 20MG | TABLET (IMMEDIATE AND DELAYED-RELEASE) | Avoided shortage | 2020-09-30 | 2020-09-30 | 125302 |
| MYLAN-NAPROXEN/ESOMEPRAZOLE MR | 375MG 20MG | TABLET (IMMEDIATE AND DELAYED-RELEASE) | Resolved | 2020-10-15 | 2021-03-17 | 126398 |
| MYLAN-NAPROXEN/ESOMEPRAZOLE MR | 500MG 20MG | TABLET (IMMEDIATE AND DELAYED-RELEASE) | Avoided shortage | 2020-10-15 | 2020-11-03 | 126401 |
| MYLAN-NAPROXEN/ESOMEPRAZOLE MR | 500MG 20MG | TABLET (IMMEDIATE AND DELAYED-RELEASE) | Resolved | 2020-12-01 | 2021-02-03 | 129187 |
| MYLAN-NAPROXEN/ESOMEPRAZOLE MR | 375MG 20MG | TABLET (IMMEDIATE AND DELAYED-RELEASE) | Resolved | 2021-03-17 | 2021-04-19 | 135792 |
| MYLAN-NAPROXEN/ESOMEPRAZOLE MR | 20MG 500MG | TABLET (IMMEDIATE AND DELAYED-RELEASE) | Resolved | 2021-12-21 | 2022-01-04 | 151663 |
| MYLAN-NAPROXEN/ESOMEPRAZOLE MR | 20MG 500MG | TABLET (IMMEDIATE AND DELAYED-RELEASE) | Resolved | 2022-01-13 | 2022-07-08 | 152651 |
| MYLAN-NAPROXEN/ESOMEPRAZOLE MR | 20MG 375MG | TABLET (IMMEDIATE AND DELAYED-RELEASE) | Resolved | 2022-07-20 | 2022-09-07 | 165092 |
| MYLAN-NAPROXEN/ESOMEPRAZOLE MR | 20MG 500MG | TABLET (IMMEDIATE AND DELAYED-RELEASE) | Resolved | 2022-10-19 | 2023-01-10 | 172186 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MYLAN-OMEPRAZOLE | 20MG | CAPSULE (DELAYED RELEASE) | Discontinued | 2018-05-04 | 2018-05-04 | 48569 |
| MYLAN-OMEPRAZOLE | 10MG | CAPSULE (DELAYED RELEASE) | Discontinued | 2018-06-12 | 2018-08-28 | 52267 |
| MYLAN-VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2017-08-24 | 2018-02-15 | 20259 |
| MYLAN-VENLAFAXINE XR | 75MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2017-08-24 | 2018-02-15 | 20287 |
| MYLAN-VENLAFAXINE XR | 150MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2017-08-24 | 2018-07-04 | 20306 |
| MYLAN-TOLTERODINE ER | 2MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2022-02-15 | 2022-02-15 | 155037 |
| MYLAN-TOLTERODINE ER | 4MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2022-02-15 | 2022-02-15 | 155040 |
| MYLAN-NITRO SUBLINGUAL SPRAY | 0.4MG | METERED-DOSE AEROSOL | Discontinued | 2024-05-08 | 2024-05-08 | 227338 |
| MYLAN-FENTANYL MATRIX PATCH | 12MCG | PATCH | Discontinued | 2018-12-04 | 2019-01-03 | 68529 |
| MYLAN-FENTANYL MATRIX PATCH | 25MCG | PATCH | Discontinued | 2018-12-04 | 2019-01-03 | 68532 |
| MYLAN-FENTANYL MATRIX PATCH | 50MCG | PATCH | Discontinued | 2018-12-04 | 2019-01-03 | 68536 |
| MYLAN-FENTANYL MATRIX PATCH | 75MCG | PATCH | Discontinued | 2018-12-04 | 2019-01-03 | 68539 |
| MYLAN-FENTANYL MATRIX PATCH | 100MCG | PATCH | Discontinued | 2018-12-04 | 2019-01-03 | 68542 |
| GEMCITABINE FOR INJECTION, USP | 1G | POWDER FOR SOLUTION | Discontinued | 2017-04-13 | 2017-04-13 | 6698 |
| GEMCITABINE FOR INJECTION, USP | 2G | POWDER FOR SOLUTION | Discontinued | 2017-04-13 | 2017-04-13 | 6701 |
| AZITHROMYCIN FOR INJECTION, USP | 500MG | POWDER FOR SOLUTION | Discontinued | 2017-07-17 | 2018-02-15 | 15804 |
| VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP | 500MG | POWDER FOR SOLUTION | Discontinued | 2018-06-06 | 2018-06-08 | 51668 |
| VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP | 1G | POWDER FOR SOLUTION | Discontinued | 2018-06-06 | 2018-06-08 | 51671 |
| VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP | 5G | POWDER FOR SOLUTION | Discontinued | 2018-06-06 | 2018-06-08 | 51674 |
| ONDANSETRON INJECTION, USP | 2MG | SOLUTION SOLUTION | Discontinued | 2022-05-11 | 2022-05-11 | 160318 |